With the birth of "the first share of the board", Guandian Defense Technology Co., Ltd. (832317, hereinafter referred to as "Guandian defense") will log on the science and Innovation Board of Shanghai Stock Exchange (hereinafter referred to as "Shanghai Stock Exchange") from Beijing stock exchange (hereinafter referred to as "Beijing stock exchange").
On the last day of March, Guandian Defense issued an announcement on the application for board transfer and its progress, saying that after examination, the Shanghai Stock Exchange agreed to the listing of the company on the science and Innovation Board of the Shanghai Stock Exchange. This decision shall be valid for 6 months from the date of making.
At the end of January this year, the municipal Party committee announced on the science and innovation board that Guandian Defense met the listing conditions and information disclosure requirements of the board, and the meeting was officially held. From the announcement expressing the intention to transfer the board to the meeting, it took less than 6 months to observe the code, and the process was rapid.
It is worth mentioning that Guandian defense is not only the first company to successfully transfer the board, but also the first company to apply for the selected layer of the new third board, but also the first company to apply for direct transfer of the selected layer.
"the first share of the board" was born, and the first listing standard of the science and Innovation Board was selected for the meeting
Guandian defense announcement said that according to the application of the company, in accordance with the relevant provisions of the company law of the people's Republic of China, the securities law of the people's Republic of China, the guiding opinions of the CSRC on the listing of companies listed on the National SME share transfer system, and the measures for the listing of companies listed on the National SME share transfer system on the science and Innovation Board of Shanghai Stock Exchange (for Trial Implementation), The Shanghai Stock Exchange agrees that the company will be listed on the science and Innovation Board of the Shanghai Stock Exchange.
Previous announcements showed that Guandian defense selected the first listing standard of the science and innovation board for this board transfer. That is, the market value is expected to be no less than RMB 1 billion, the net profit in the last two years is positive, and the cumulative net profit is no less than RMB 50 million; Or the market value is expected to be no less than RMB 1 billion, the net profit of the most recent year is positive, and the operating income is no less than RMB 100 million.
In 2019 and 2020, the net profit of Guandian defense (excluding the lower one) was 534608 million yuan and 417042 million yuan respectively, with a total of 951650 million yuan, meeting the standard I specified in the Listing Rules of the science and innovation board.
At the same time, in terms of R & D expenses, proportion of R & D personnel, patents and revenue growth, Guandian defense also meets the requirements of the guidance on the attributes of science and innovation listed on the science and innovation board.
According to the public data, the R & D investment of Guandian defense in 2018, 2019 and 2020 was 9.1978 million yuan, 175801 million yuan and 201059 million yuan respectively, accounting for 8.80%, 12.05% and 11.18% of the operating revenue respectively, meeting the requirements of more than 5% in the guidelines for the evaluation of scientific and innovative attributes (Trial).
At the same time, the proportion of R & D personnel in the total number of employees is 35.44%, which meets the requirement of no less than 10% in the guidelines for the evaluation of science and innovation attributes (Trial). It has 5 invention patents, 25 utility model patents and 16 software copyrights, which meet the requirements of more than 5 items in the guidelines for the evaluation of scientific and innovative attributes (Trial).
In addition, Guandian defense's operating revenue in 2018, 2019 and 2020 was 105 million yuan, 146 million yuan and 180 million yuan respectively, with a compound growth rate of 31.11% in recent three years, meeting the requirement of 20% in the guidelines for the evaluation of scientific and innovative attributes (Trial).
board transfer process is rapid
According to relevant regulations, the transfer of the board from the Beijing stock exchange to the Shanghai and Shenzhen markets does not require the issuance of new shares and is already a listed company, so it does not need the re approval or registration of the CSRC. Therefore, after the meeting on January 27 this year, Guandian defense has become the first board transfer company after the establishment of the Beijing stock exchange.
It is worth mentioning that Guandian defense is not only the first company to successfully transfer the board, but also the first company to apply for the selected layer of the new third board, but also the first company to apply for direct transfer of the selected layer.
In addition, it took less than six months for Guandian defense to express its intention to transfer the board from the announcement to the meeting, and the process was rapid.
On August 12, 2021, Guandian defense announcement began to promote the board transfer process.
On October 20, 2021, Guandian defense submitted an application for listing on the science and innovation board to the Shanghai Stock Exchange.
On November 10, 2021, Guandian defense board transfer application was accepted by Shanghai Stock Exchange.
The first and second rounds of inquiries were received on December 13, 2021 and 2023, respectively.
On January 27, 2022, Guandian defense officially held the meeting.
On March 31, 2022, the Shanghai Stock Exchange agreed to the listing application of Guandian defense board to the science and Innovation Board of the Shanghai Stock Exchange.
continuous growth in performance in recent three years
Statistics show that Guandian defense is a leading UAV service provider in China and the first enterprise in China to engage in UAV drug control product R & D and service industrialization.
According to the report on the listing of Guandian defense board (the last draft), Guandian defense's main business includes UAV flight service and data processing, R & D, production and sales of UAV Systems and intelligent defense equipment. Its business covers drug control, counter-terrorism, resource investigation, environmental monitoring and other fields, especially in the field of drug control.
In terms of performance, Guandian defense's performance has continued to grow in recent three years.
Specifically, from 2018 to 2020, the operating revenue reached 105 million yuan, 146 million yuan and 180 million yuan respectively, and the net profit attributable to the parent company was 205706 million yuan, 417042 million yuan and 534608 million yuan respectively.
In the first three quarters of 2021, Guandian defense achieved a revenue of 175 million yuan and a net profit of 612309 million yuan.
